We are thrilled to announce that Linnea’s GMP certificate just got a major upgrade with Swissmedic approval for an expanded range of cannabis-based formulations, namely THC extracts and combinations, along with Cannabigerol and CBD:CBG combinations.
This update reflects our ongoing commitment to quality, compliance, and innovation in developing precise, standardized extracts for therapeutic use, while also strengthening our regulatory standing and enabling us to better meet the evolving needs of patients and healthcare professionals seeking reliable, high-quality cannabis solutions.
A huge thank you to our team whose expertise and dedication made this possible. We look forward to continuing our journey of innovation and excellence in the field of cannabis-based therapies.
